Annual Report — Form 10-K — Sect. 13 / 15(d) – SEA’34 Filing Table of Contents
Document/ExhibitDescriptionPagesSize
1: 10-K Annual Report HTML 927K
2: EX-10.CC Material Contract HTML 48K
3: EX-10.I Material Contract HTML 285K
4: EX-10.S Material Contract HTML 68K
5: EX-10.U Material Contract HTML 69K
7: EX-21 Subsidiaries List HTML 36K
8: EX-23 Consent of Experts or Counsel HTML 39K
9: EX-24 Power of Attorney HTML 91K
6: EX-12 Statement re: Computation of Ratios HTML 48K
10: EX-31.A Certification -- §302 - SOA'02 HTML 43K
11: EX-31.B Certification -- §302 - SOA'02 HTML 43K
12: EX-32.A Certification -- §906 - SOA'02 HTML 38K
13: EX-32.B Certification -- §906 - SOA'02 HTML 38K
20: R1 Document and Entity Information HTML 65K
21: R2 Consolidated Statements of Operations HTML 113K
22: R3 Consolidated Statements of Comprehensive Income HTML 54K
23: R4 Consolidated Statements of Comprehensive Income HTML 43K
(Parenthetical)
24: R5 Consolidated Statements of Financial Position HTML 134K
25: R6 Consolidated Statements of Financial Position HTML 58K
(Parenthetical)
26: R7 Consolidated Statements of Cash Flows HTML 148K
27: R8 Consolidated Statements of Cash Flows HTML 40K
(Parenthetical)
28: R9 Consolidated Statements of Shareholders' HTML 87K
Investment
29: R10 Summary of Accounting Policies HTML 46K
30: R11 Revenues HTML 43K
31: R12 Cost of Sales and Selling, General and HTML 44K
Administrative Expenses
32: R13 Consideration Received from Vendors HTML 40K
33: R14 Advertising Costs HTML 47K
34: R15 Pharmacies Transaction HTML 102K
35: R16 Canada Exit HTML 102K
36: R17 Restructuring Initiatives HTML 40K
37: R18 Credit Card Profit Sharing HTML 39K
38: R19 Fair Value Measurements HTML 79K
39: R20 Cash Equivalents HTML 42K
40: R21 Inventory HTML 42K
41: R22 Other Current Assets HTML 47K
42: R23 Property and Equipment HTML 55K
43: R24 Other Noncurrent Assets HTML 48K
44: R25 Goodwill and Intangible Assets HTML 74K
45: R26 Accounts Payable HTML 39K
46: R27 Accrued and Other Current Liabilities HTML 54K
47: R28 Commitments and Contingencies HTML 49K
48: R29 Notes Payable and Long-Term Debt HTML 77K
49: R30 Derivative Financial Instruments HTML 80K
50: R31 Leases HTML 83K
51: R32 Income Taxes HTML 111K
52: R33 Other Noncurrent Liabilities HTML 51K
53: R34 Share Repurchase HTML 46K
54: R35 Share-Based Compensation HTML 110K
55: R36 Defined Contribution Plans HTML 56K
56: R37 Pension and Postretirement Health Care Plans HTML 194K
57: R38 Accumulated Other Comprehensive Income HTML 61K
58: R39 Segment Reporting HTML 88K
59: R40 Quarterly Results (Unaudited) HTML 243K
60: R41 Summary of Accounting Policies (Policies) HTML 149K
61: R42 Advertising Costs (Tables) HTML 47K
62: R43 Pharmacies Transaction (Tables) HTML 71K
63: R44 Canada Exit (Tables) HTML 98K
64: R45 Fair Value Measurements (Tables) HTML 78K
65: R46 Other Current Assets (Tables) HTML 47K
66: R47 Property and Equipment (Tables) HTML 54K
67: R48 Other Noncurrent Assets (Tables) HTML 48K
68: R49 Goodwill and Intangible Assets (Tables) HTML 69K
69: R50 Accrued and Other Current Liabilities (Tables) HTML 54K
70: R51 Notes Payable and Long-Term Debt (Tables) HTML 79K
71: R52 Derivative Financial Instruments (Tables) HTML 76K
72: R53 Leases (Tables) HTML 76K
73: R54 Income Taxes (Tables) HTML 109K
74: R55 Other Noncurrent Liabilities (Tables) HTML 50K
75: R56 Share Repurchase (Tables) HTML 47K
76: R57 Share-Based Compensation (Tables) HTML 109K
77: R58 Defined Contribution Plans (Tables) HTML 52K
78: R59 Pension and Postretirement Health Care Plans HTML 199K
(Tables)
79: R60 Accumulated Other Comprehensive Income (Tables) HTML 58K
80: R61 Segment Reporting (Tables) HTML 84K
81: R62 Quarterly Results (Unaudited) (Tables) HTML 244K
82: R63 Summary of Accounting Policies (Details) HTML 42K
83: R64 Revenues (Details) HTML 48K
84: R65 Advertising Costs (Details) HTML 43K
85: R66 Pharmacies Transaction - Narrative (Details) HTML 51K
86: R67 Pharmacies Transaction - Schedule of Gain on HTML 66K
Pharmacies and Clinics Transaction (Details)
87: R68 Canada Exit - Narrative (Details) HTML 55K
88: R69 Canada Exit - Schedule of Income/(Loss) on HTML 75K
Discontinued Operations (Details)
89: R70 Canada Exit - Schedule of Pretax Exit Costs HTML 48K
(Details)
90: R71 Canada Exit - Schedule of Assets and Liabilities HTML 54K
of Discontinued Operations (Details)
91: R72 Restructuring Initiatives - Narrative (Details) HTML 43K
92: R73 Credit Card Profit Sharing (Details) HTML 39K
93: R74 Fair Value Measurements - Schedule of Fair Value HTML 66K
Measurements - Recurring Basis (Details)
94: R75 Fair Value Measurements - Schedule of Significant HTML 43K
Financial Instruments not Measured at Fair Value
(Details)
95: R76 Cash Equivalents (Details) HTML 44K
96: R77 Inventory (Details) HTML 39K
97: R78 Other Current Assets (Details) HTML 47K
98: R79 Property and Equipment (Details) HTML 62K
99: R80 Other Noncurrent Assets (Details) HTML 47K
100: R81 Goodwill and Intangible Assets - Narrative HTML 50K
(Details)
101: R82 Goodwill and Intangible Assets - Schedule of HTML 65K
Intangible Assets (Details)
102: R83 Goodwill and Intangible Assets - Schedule of HTML 48K
Estimated Amortization Expense (Details)
103: R84 Accounts Payable (Details) HTML 40K
104: R85 Accrued and Other Current Liabilities (Details) HTML 63K
105: R86 Commitments and Contingencies - Narrative HTML 65K
(Details)
106: R87 Notes Payable and Long-Term Debt - Narrative HTML 73K
(Details)
107: R88 Notes Payable and Long-Term Debt - Schedule of HTML 66K
Carrying Value and Maturities of Debt Portfolio
(Details)
108: R89 Notes Payable and Long-Term Debt - Schedule of HTML 50K
Required Principal Payments (Details)
109: R90 Notes Payable and Long-Term Debt - Schedule of HTML 47K
Commercial Paper (Details)
110: R91 Derivative Financial Instruments - Narrative HTML 43K
(Details)
111: R92 Derivative Financial Instruments - Schedule of HTML 53K
Outstanding Interest Rate Swap Summary (Details)
112: R93 Derivative Financial Instruments - Schedule of HTML 55K
Classification and Fair Value (Details)
113: R94 Derivative Financial Instruments - Schedule of HTML 41K
Derivative Contracts - Effect on Results of
Operations (Details)
114: R95 Leases - Narrative (Details) HTML 53K
115: R96 Leases - Schedule of Rent Expense (Details) HTML 43K
116: R97 Leases - Schedule of Future Minimum Lease Payments HTML 117K
(Details)
117: R98 Income Taxes - Narrative (Details) HTML 66K
118: R99 Income Taxes - Schedule of Tax Rate Reconciliation HTML 58K
- Continuing Operations (Details)
119: R100 Income Taxes - Schedule of Provision for Income HTML 72K
Taxes (Details)
120: R101 Income Taxes - Schedule of Net Deferred Tax HTML 71K
Asset/(Liability) (Details)
121: R102 Income Taxes - Schedule of Reconciliation of HTML 50K
Liability for Unrecognized Tax Benefits (Details)
122: R103 Other Noncurrent Liabilities (Details) HTML 57K
123: R104 Share Repurchase - Schedule of Share Repurchases HTML 44K
(Details)
124: R105 Share-Based Compensation - Narrative (Details) HTML 93K
125: R106 Share-Based Compensation - Schedule of Restricted HTML 73K
Stock Activity and Performance Share Unit Activity
(Details)
126: R107 Share-Based Compensation - Schedule of Stock HTML 71K
Option Activity (Details)
127: R108 Share-Based Compensation - Schedule of Stock HTML 44K
Option Exercises (Details)
128: R109 Defined Contribution Plans (Details) HTML 63K
129: R110 Pension and Postretirement Health Care Plans - HTML 52K
Schedule of Recognition of Funded/(Underfunded)
Status (Details)
130: R111 Pension and Postretirement Health Care Plans - HTML 52K
Schedule of Estimated Future Benefit Payments
(Details)
131: R112 Pension and Postretirement Health Care Plans - HTML 58K
Schedule of Net Pension Benefit Expense (Details)
132: R113 Pension and Postretirement Health Care Plans - HTML 43K
Schedule of Benefit Obligation Weighted Average
Assumptions (Details)
133: R114 Pension and Postretirement Health Care Plans - HTML 46K
Schedule of Net Periodic Benefit Expense Weighted
Average Assumptions (Details)
134: R115 Pension and Postretirement Health Care Plans - HTML 78K
Narrative (Details)
135: R116 Pension and Postretirement Health Care Plans - HTML 64K
Schedule of Change in Projected Benefit Obligation
(Details)
136: R117 Pension and Postretirement Health Care Plans - HTML 61K
Schedule of Change in Plan Assets (Details)
137: R118 Pension and Postretirement Health Care Plans - HTML 61K
Schedule of Asset Category (Details)
138: R119 Pension and Postretirement Health Care Plans - HTML 64K
Schedule of Fair Value Measurements (Details)
139: R120 Pension and Postretirement Health Care Plans - HTML 57K
Schedule of Amounts in Accumulated Other
Comprehensive Income (Details)
140: R121 Accumulated Other Comprehensive Income (Details) HTML 74K
141: R122 Segment Reporting - Schedule of Business Segment HTML 79K
Results (Details)
142: R123 Segment Reporting - Schedule of Total Assets by HTML 46K
Segments (Details)
143: R124 Quarterly Results (Unaudited) - Schedule of HTML 115K
Quarterly Results (Details)
144: R125 Quarterly Results (Unaudited) - Summary of Sales HTML 59K
by Product Category (Details)
146: XML IDEA XML File -- Filing Summary XML 265K
145: EXCEL IDEA Workbook of Financial Reports XLSX 136K
14: EX-101.INS XBRL Instance -- tgt-20170128 XML 3.69M
16: EX-101.CAL XBRL Calculations -- tgt-20170128_cal XML 404K
17: EX-101.DEF XBRL Definitions -- tgt-20170128_def XML 842K
18: EX-101.LAB XBRL Labels -- tgt-20170128_lab XML 2.55M
19: EX-101.PRE XBRL Presentations -- tgt-20170128_pre XML 1.50M
15: EX-101.SCH XBRL Schema -- tgt-20170128 XSD 296K
147: ZIP XBRL Zipped Folder -- 0000027419-17-000008-xbrl Zip 345K
PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report on Form 10-K of Target Corporation, a Minnesota corporation (“the Company”), for the year ended January 28, 2017, as filed with the Securities and Exchange Commission on the date hereof (“the Report”),
the undersigned officer of the Company certifies pursuant to 18 U.S.C. Section 1350, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to her knowledge:
1. the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
2. the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
A
signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.